ENZO BIOCHEM INC's ticker is ENZ and the CUSIP is 294100102. A total of 84 filers reported holding ENZO BIOCHEM INC in Q3 2020. The put-call ratio across all filers is 0.90 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,180,257 | -49.4% | 843,086 | -33.5% | 0.00% | -100.0% |
| Q2 2023 | $2,331,674 | -36.9% | 1,267,075 | -16.7% | 0.00% | 0.0% |
| Q1 2023 | $3,697,381 | +160029.1% | 1,521,683 | -5.7% | 0.00% | 0.0% |
| Q4 2022 | $2,309 | -99.9% | 1,614,450 | +1.3% | 0.00% | 0.0% |
| Q3 2022 | $3,554,000 | +7.1% | 1,593,865 | -0.5% | 0.00% | 0.0% |
| Q2 2022 | $3,317,000 | -28.3% | 1,602,375 | +0.5% | 0.00% | 0.0% |
| Q1 2022 | $4,624,000 | -9.8% | 1,594,541 | -0.1% | 0.00% | -50.0% |
| Q4 2021 | $5,126,000 | -6.8% | 1,596,839 | +2.7% | 0.00% | 0.0% |
| Q3 2021 | $5,502,000 | +8.9% | 1,554,149 | -2.5% | 0.00% | 0.0% |
| Q2 2021 | $5,053,000 | -10.1% | 1,594,061 | -2.4% | 0.00% | 0.0% |
| Q1 2021 | $5,618,000 | +30.8% | 1,633,223 | -4.1% | 0.00% | 0.0% |
| Q4 2020 | $4,294,000 | +5.8% | 1,703,788 | -11.4% | 0.00% | 0.0% |
| Q3 2020 | $4,058,000 | -7.7% | 1,923,366 | -2.0% | 0.00% | 0.0% |
| Q2 2020 | $4,396,000 | -15.9% | 1,962,709 | -5.0% | 0.00% | -33.3% |
| Q1 2020 | $5,228,000 | -6.6% | 2,066,365 | -2.9% | 0.00% | +50.0% |
| Q4 2019 | $5,597,000 | -27.5% | 2,128,200 | -0.7% | 0.00% | -33.3% |
| Q3 2019 | $7,715,000 | +7.0% | 2,142,985 | +0.1% | 0.00% | 0.0% |
| Q2 2019 | $7,213,000 | +25.6% | 2,140,479 | +1.7% | 0.00% | +50.0% |
| Q1 2019 | $5,745,000 | +1.8% | 2,104,448 | +3.7% | 0.00% | -33.3% |
| Q4 2018 | $5,643,000 | -32.9% | 2,030,043 | -0.6% | 0.00% | 0.0% |
| Q3 2018 | $8,415,000 | -19.0% | 2,042,601 | +2.0% | 0.00% | -25.0% |
| Q2 2018 | $10,393,000 | -6.1% | 2,002,571 | -0.8% | 0.00% | -20.0% |
| Q1 2018 | $11,068,000 | -35.1% | 2,019,650 | -3.4% | 0.01% | -28.6% |
| Q4 2017 | $17,042,000 | -24.2% | 2,090,963 | -2.7% | 0.01% | -30.0% |
| Q3 2017 | $22,490,000 | +0.5% | 2,148,017 | +6.0% | 0.01% | 0.0% |
| Q2 2017 | $22,376,000 | +45.8% | 2,026,647 | +10.5% | 0.01% | +42.9% |
| Q1 2017 | $15,345,000 | +17.2% | 1,833,401 | -2.8% | 0.01% | 0.0% |
| Q4 2016 | $13,093,000 | +35.9% | 1,886,532 | -0.3% | 0.01% | +40.0% |
| Q3 2016 | $9,635,000 | -11.0% | 1,892,842 | +4.4% | 0.01% | -16.7% |
| Q2 2016 | $10,829,000 | +41.6% | 1,813,930 | +7.9% | 0.01% | +20.0% |
| Q1 2016 | $7,647,000 | +11.1% | 1,680,645 | +9.9% | 0.01% | +25.0% |
| Q4 2015 | $6,882,000 | +39.6% | 1,529,369 | -1.7% | 0.00% | +33.3% |
| Q3 2015 | $4,930,000 | -5.4% | 1,555,096 | -9.6% | 0.00% | 0.0% |
| Q2 2015 | $5,210,000 | -2.0% | 1,719,631 | -4.6% | 0.00% | 0.0% |
| Q1 2015 | $5,316,000 | -36.6% | 1,802,080 | -4.6% | 0.00% | -50.0% |
| Q4 2014 | $8,383,000 | -15.7% | 1,888,054 | -2.2% | 0.01% | -14.3% |
| Q3 2014 | $9,944,000 | -2.3% | 1,930,764 | -0.4% | 0.01% | 0.0% |
| Q2 2014 | $10,180,000 | +24.9% | 1,939,198 | -1.0% | 0.01% | +16.7% |
| Q1 2014 | $8,150,000 | +41.7% | 1,959,141 | -0.5% | 0.01% | +50.0% |
| Q4 2013 | $5,751,000 | +15.8% | 1,969,685 | -0.0% | 0.00% | 0.0% |
| Q3 2013 | $4,966,000 | +20.5% | 1,970,616 | -0.5% | 0.00% | 0.0% |
| Q2 2013 | $4,121,000 | – | 1,981,453 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roumell Asset Management, LLC | 2,436,771 | $7,822,000 | 10.43% |
| VIEX Capital Advisors, LLC | 1,736,087 | $5,573,000 | 8.96% |
| HARBERT FUND ADVISORS, INC. | 5,175,913 | $16,615,000 | 4.19% |
| AMH Equity Ltd | 596,742 | $1,916,000 | 2.66% |
| Potomac Capital Management, Inc. | 208,000 | $668,000 | 0.59% |
| Agate Pass Investment Management, LLC | 24,292 | $78,000 | 0.05% |
| RBF Capital, LLC | 250,359 | $804,000 | 0.05% |
| KEMPNER CAPITAL MANAGEMENT INC. | 25,475 | $82,000 | 0.05% |
| Corsair Capital Management | 58,657 | $188,000 | 0.04% |
| BOOTHBAY FUND MANAGEMENT, LLC | 319,500 | $1,026,000 | 0.02% |